This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
XYZ Strengthens Portfolio With New Square App: Time to Buy the Stock?
by Aniruddha Ganguly
Block is suffering from stiff competition despite an expanding partner base and strong positioning in the digital payments industry amid a stretched valuation.
Stem to Report Q1 Earnings: What's in the Cards for the Stock?
by Zacks Equity Research
STEM's first-quarter 2025 performance is expected to have benefited from PowerTrack momentum and cost cuts amid continued weakness in hardware sales.
Snap to Report Q1 Earnings: Key Metrics and Expectations to Watch
by Zacks Equity Research
SNAP's Q1 revenues are likely to have benefited from Snapchat+ growth. However, operating costs are likely to have increased due to a shift in marketing expenses.
Does Affirm Holdings (AFRM) Have the Potential to Rally 47.2% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 47.2% in Affirm Holdings (AFRM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
APH Q1 Earnings Gain From Communications Sales: Time to Buy or Hold?
by Zacks Equity Research
Amphenol shines in first-quarter 2025 with record Communications Solutions sales, though aerospace weakness and rising capex may challenge its growth trajectory.
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Opera Limited to Report Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
OPRA's first-quarter 2025 results are likely to have benefited from strong advertising revenue growth, continued AI integration, and steady product innovation.
Charter Communications to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
CHTR's rural buildout is likely to have supported Q1 growth, partly offset by wildfire-related loss in passings.
MNDY Shares Decline 21% in 6 Months: Should You Buy, Sell or Hold?
by Zacks Equity Research
MNDY's AI-powered products and platform scalability hold promise. However, slowing revenue growth and narrowing margins suggest near-term caution for investors.
Affirm Holdings, Inc. (AFRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Affirm Holdings (AFRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Block vs. Affirm: Which Fintech Stock Should You Consider Now?
by Nilanshi Mukherjee
XYZ and AFRM are well-known players in the rapidly evolving fintech sector. Which one is a better investment option right now?
The Zacks Analyst Blog Highlights Affirm, StoneCo, ACI Worldwide, Coinbase Global and OppFi
by Zacks Equity Research
Affirm, StoneCo, ACI Worldwide, Coinbase Global and OppFi are part of the Zacks top Analyst Blog.
MSCI Gears Up to Report Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
MSCI's first-quarter 2025 performance is expected to have benefited from strong Climate and ESG solutions adoption amid ongoing market uncertainties.
Affirm vs. PayPal: Which Fintech Stock Should You Invest in Now?
by Kaibalya Pravo Dey
Over the past year, AFRM stock has experienced significant swings, both up and down. PYPL, on the other hand, has been more stable.
5 Must-Buy Fintech Stocks to Maximize Returns Over the Long Term
by Nalak Das
Buy 5 Fintech stocks to reap benefits over the long term. These are: AFRM, ACIW, STNE, OPFI, COIN.
Best Mobile Payments Stocks to Add to Your Portfolio for Strong Growth
by Kaibalya Pravo Dey
For investors, top mobile payment companies like AFRM, FI, MELI and PAY offer attractive opportunities thanks to their strong focus on innovation and ongoing market expansion.
Should You Buy The New York Times Stock at Its Discounted Price?
by Zacks Equity Research
The New York Times stock appears undervalued, with its digital growth outweighing the decline in its print business.
Federal Mandates Drive Workiva: Buy, Sell or Hold the Stock?
by Zacks Equity Research
Workiva takes center stage as U.S. agencies race to meet strict financial upgrade mandates.
Top Stock Picks for Week of April 14, 2025
by Panel Of Zacks Experts
A Financial Technology Company Expected to Offer Substantial Upside Potential and a Futures Exchange with Solid Estimate Activity.
Wall Street Analysts Think Affirm Holdings (AFRM) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Affirm Holdings (AFRM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Top Fintech Stocks to Add to Your Portfolio for Robust Returns
by Swayta Shah
The fintech industry is set to keep growing. To capitalize on this momentum, you can bet on companies like IBKR, AFRM and BGC to generate strong returns.
Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks
by Sanghamitra Saha
Top-ranked stocks Fox (FOXA), Roku (ROKU), Fortinet (FTNT), Okta (OKTA) and Affirm (AFRM) are likely to beat on the bottom line in their upcoming releases.
Buy 5 Top-Ranked Internet Software Stocks for Solid Short-Term Returns
by Nalak Das
Buy five Internet Software stocks for attractive near-term gains. These are: AFRM, FIVN, U, OLO, STNE.
Affirm Holdings (AFRM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Affirm Holdings (AFRM) closed at $40.49, marking a -0.61% move from the previous day.
Artificial Intelligence Fuels Genpact's Growth, High Talent Costs Ail
by Zacks Equity Research
The G stock is benefiting from enhancing its client's business processes utilizing Digital SEPs.